Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Jazz Pharmaceuticals plc buy The Goldman Sachs Group, Inc.

Jazz Pharmaceuticals plc
Start price
€109.20
29.08.25 / 50%
Target price
€158.67
29.08.26
Performance (%)
47.25%
Price
€160.80
27.02.26
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc has seen massive gains of 47.25%. This prediction currently runs until 29.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Jazz Pharmaceuticals plc 10.099% 10.099%
iShares Core DAX® -0,38 % 1,09 %
iShares Nasdaq 100 -0,41 % -1,97 %
iShares Nikkei 225® 1,84 % 10,26 %
iShares S&P 500 -0,71 % 0,44 %

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Jazz Pharmaceuticals plc diskutieren
Prediction Buy
Perf. (%) 47.25%
Target price 158.675
Change
Ends at 29.08.26

Jazz Pharmaceuticals (NASDAQ:JAZZ) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $162.00 to $185.00. They now have a "buy" rating on the stock.
Ratings data for JAZZ provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
29.08.25

Stopped prediction by The_Goldman_Sachs_Gr for Jazz Pharmaceuticals plc

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€98.06
05.06.24
€155.23
05.06.25
-1.35%
06.06.25

The Goldman Sachs Group, Inc. 
05.06.24 50%
buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€137.36
03.03.23
€199.47
03.03.24
-19.63%
04.03.24

The Goldman Sachs Group, Inc. 
03.03.23 50%